QHP Capital Acquires Principal IRB and Rebrands It as Univo IRB
February 21, 2024
QHP Capital has acquired Principal IRB and relaunched the business as Univo IRB, a next-generation institutional review board focused on agile IRB review services for clinical trials. The investment positions QHP to build and scale a tech-enabled life sciences services platform, leveraging Univo's accredited IRB team and industry-focused technologies to support sponsors, CROs, and device companies.
- Buyers
- QHP Capital
- Targets
- Univo IRB (formerly Principal IRB)
- Industry
- Healthcare Services
- Location
- North Carolina, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.